- Home
- Equipment
- usa new york
- clinical send out testing
Refine by
Clinical Send Out Testing Equipment Supplied In Usa New York
6 equipment items found
Manufactured by:International Flavors & Fragrances (IFF) based inNew York, NEW YORK (USA)
Curcugen™ is a highly concentrated, clinically studied curcumin ingredient, fully derived from a turmeric base with a high, 50% curcuminoid concentration. It is derived from turmeric oleoresin as base ingredient with a more comprehensive profile of turmeric bioactives than the industry-standard starting material, 95% curcuminoids. The oleoresin is the native matrix where turmeric’s ...
Manufactured by:Shenzhen AIVD Biotechnology Co. , LTD. based inCheektowaga, NEW YORK (USA)
Calibration is the foundation of all clinical laboratory testing that insures the accurate reporting of patient results. Calibration is the process that links the analytical signal with the concentration of analyte present in serum, urine or other body ...
Manufactured by:Auro Vaccines LLC based inPearl River, NEW YORK (USA)
Auro Vaccines is developing a GeneVax prime/VesiculoVax boost therapeutic HPV vaccine for use as an adjunct to surgery that targets the seven HPV types responsible for more than 92% of cervical and head and neck ...
Manufactured by:Polymedco, LLC based inCortlandt Manor, NEW YORK (USA)
OC-Auto FIT is a fecal immunochemical test (FIT) designed to enhance colorectal cancer screening by offering a highly accurate and clinically supported method. The test is geared towards individuals aged 45 to 75, adhering to Tier 1 guidelines, making it a critical tool in preventive healthcare. It boasts superior sensitivity and specificity, thereby effectively identifying patients who require ...
Manufactured by:Scopus BioPharma based inNew York, NEW YORK (USA)
We are developing MRI-1867, our licensed rationally designed, orally available, dual-action, hybrid, small molecule that is an inverse agonist of the CB1 receptor, as well as an inhibitor of the iNOS ...
Manufactured by:Scopus BioPharma based inNew York, NEW YORK (USA)
Our licensed gene therapy, CO-sTiRNA™, is a dual-action STAT3 inhibitor. STAT3 is a gene that drives tumor cell growth and anti-tumor immune suppression. CO-sTiRNA™ is a highly selective and targeted gene therapy that silences the activity of the STAT3 gene by way of RNA interference. CO-sTiRNA™ also stimulates TLR9 receptors to activate the body’s immune defense to ...